20 research outputs found
Detection of Na, K, and H<sub>2</sub>O in the hazy atmosphere of WASP-6b
We present new observations of the transmission spectrum of the hot Jupiter WASP-6b both from the ground with the Very Large Telescope FOcal Reducer and Spectrograph (FORS2) from 0.45 to 0.83 μm, and space with the Transiting Exoplanet Survey Satellite from 0.6 to 1.0 μm and the Hubble Space Telescope (HST) Wide Field Camera 3 from 1.12 to 1.65 μm. Archival data from the HST Space Telescope Imaging Spectrograph (STIS) and Spitzer are also re-analysed on a common Gaussian process framework, of which the STIS data show a good overall agreement with the overlapping FORS2 data. We also explore the effects of stellar heterogeneity on our observations and its resulting implications towards determining the atmospheric characteristics of WASP-6b. Independent of our assumptions for the level of stellar heterogeneity we detect Na I, K I, and H2O absorption features and constrain the elemental oxygen abundance to a value of [O/H] ≃ -0.9 ± 0.3 relative to solar. In contrast, we find that the stellar heterogeneity correction can have significant effects on the retrieved distributions of the [Na/H] and [K/H] abundances, primarily through its degeneracy with the sloping optical opacity of scattering haze species within the atmosphere. Our results also show that despite this presence of haze, WASP-6b remains a favourable object for future atmospheric characterization with upcoming missions such as the James Webb Space Telescope
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
BACKGROUND: Staphylococcus aureus bacteraemia is a common cause of severe community-acquired and hospital-acquired infection worldwide. We tested the hypothesis that adjunctive rifampicin would reduce bacteriologically confirmed treatment failure or disease recurrence, or death, by enhancing early S aureus killing, sterilising infected foci and blood faster, and reducing risks of dissemination and metastatic infection. METHODS: In this multicentre, randomised, double-blind, placebo-controlled trial, adults (≥18 years) with S aureus bacteraemia who had received ≤96 h of active antibiotic therapy were recruited from 29 UK hospitals. Patients were randomly assigned (1:1) via a computer-generated sequential randomisation list to receive 2 weeks of adjunctive rifampicin (600 mg or 900 mg per day according to weight, oral or intravenous) versus identical placebo, together with standard antibiotic therapy. Randomisation was stratified by centre. Patients, investigators, and those caring for the patients were masked to group allocation. The primary outcome was time to bacteriologically confirmed treatment failure or disease recurrence, or death (all-cause), from randomisation to 12 weeks, adjudicated by an independent review committee masked to the treatment. Analysis was intention to treat. This trial was registered, number ISRCTN37666216, and is closed to new participants. FINDINGS: Between Dec 10, 2012, and Oct 25, 2016, 758 eligible participants were randomly assigned: 370 to rifampicin and 388 to placebo. 485 (64%) participants had community-acquired S aureus infections, and 132 (17%) had nosocomial S aureus infections. 47 (6%) had meticillin-resistant infections. 301 (40%) participants had an initial deep infection focus. Standard antibiotics were given for 29 (IQR 18-45) days; 619 (82%) participants received flucloxacillin. By week 12, 62 (17%) of participants who received rifampicin versus 71 (18%) who received placebo experienced treatment failure or disease recurrence, or died (absolute risk difference -1·4%, 95% CI -7·0 to 4·3; hazard ratio 0·96, 0·68-1·35, p=0·81). From randomisation to 12 weeks, no evidence of differences in serious (p=0·17) or grade 3-4 (p=0·36) adverse events were observed; however, 63 (17%) participants in the rifampicin group versus 39 (10%) in the placebo group had antibiotic or trial drug-modifying adverse events (p=0·004), and 24 (6%) versus six (2%) had drug interactions (p=0·0005). INTERPRETATION: Adjunctive rifampicin provided no overall benefit over standard antibiotic therapy in adults with S aureus bacteraemia. FUNDING: UK National Institute for Health Research Health Technology Assessment
Kinetic energy
In the academic culture, science and art are often viewed as wholly separate intellectual spheres. When the two disciplines are juxtaposed, however, a researcher may have the ability to understand each discipline, and the relationship between the two disciplines, more deeply. Science has the potential to provide inspiration for art, and art has the ability to explain science. In the dance performance concert Kinetic Energy, scientific concepts such as the research process, the Ideal Gas Law, magnetic fields, waves, the Universe, and the physiology of the human heart, are expressed through dance. The purpose of this expression was to provide the dance community with exposure to scientific concepts and to provide the scientific community with an opportunity to broaden their creativity and viewpoint of concepts they may have previously studied.Honors CollegeThesis (B.?.
Kinetic energy
In the academic culture, science and art are often viewed as wholly separate intellectual spheres. When the two disciplines are juxtaposed, however, a researcher may have the ability to understand each discipline, and the relationship between the two disciplines, more deeply. Science has the potential to provide inspiration for art, and art has the ability to explain science. In the dance performance concert Kinetic Energy, scientific concepts such as the research process, the Ideal Gas Law, magnetic fields, waves, the Universe, and the physiology of the human heart, are expressed through dance. The purpose of this expression was to provide the dance community with exposure to scientific concepts and to provide the scientific community with an opportunity to broaden their creativity and viewpoint of concepts they may have previously studied.Thesis (B.?.)Honors Colleg
Universal tool for vaccine scheduling: applications for children and adults
To improve coverage against vaccine-preventable diseases for children and adults, and to aid caretakers and providers in making appropriate and timely vaccination decisions, Georgia Institute of Technology collaborated with the Centers for Disease Control and Prevention to develop decision support tools for creating optimized catch-up immunization schedules for four target groups: children through age 6, adolescents ages 7 through 18, adults ages 19 and over in the United States, and children and adolescents through age 19 in Canada. Our solution to the catch-up scheduling problem for each targeted group determines the best coverage schedule for each individual given his (her) vaccination history and age. If an individual misses one or more doses of a recommended vaccine, a health-care professional is typically responsible for generating a feasible catch-up schedule that optimizes the person's coverage against vaccine-preventable diseases, a task that is often challenging and time consuming. Inappropriate schedules could prevent some individuals from being vaccinated in a timely manner, potentially increasing their risk of contracting a disease. Each decision support tool uses a dynamic programming algorithm to construct recommended immunization schedules in an optimized manner. These tools simplify the tedious process of manually constructing immunization schedules, expedite the process, and eliminate errors
Public health modeling at the Centers for Disease Control and Prevention
At the Centers for Disease Control and Prevention, there is a growing interest in promoting the use of mathematical modeling to support public health policies. This chapter presents three examples of operations research models developed and employed by the Centers for Disease Control and Prevention. First, we discuss the Adult Immunization Scheduler, which uses dynamic programming methods to establish a personalized vaccination schedule for adults aged 19 and older. The second operations research project is a discrete event simulation model used to estimate the throughput and budget for mass vaccination clinics during the 2009-2010 H1N1 pandemic. Lastly, we describe a national HIV resource allocation model that uses nonlinear programming methods to optimize the allocation of funds to HIV prevention programs and populations
Solar-to-supersolar sodium and oxygen absolute abundances for a "hot Saturn" orbiting a metal-rich star
We present new analysis of infrared transmission spectroscopy of the
cloud-free hot-Saturn WASP-96b performed with the Hubble and Spitzer Space
Telescopes (HST and Spitzer). The WASP-96b spectrum exhibits the absorption
feature from water in excellent agreement with synthetic spectra computed
assuming a cloud-free atmosphere. The HST-Spitzer spectrum is coupled with Very
Large Telescope (VLT) optical transmission spectroscopy which reveals the full
pressure-broadened profile of the sodium absorption feature and enables the
derivation of absolute abundances. We confirm and correct for a spectral offset
of of the
VLT data relative to the HST-Spitzer spectrum. This offset can be explained by
the assumed radius for the common-mode correction of the VLT spectra, which is
a well-known feature of ground-based transmission spectroscopy. We find
evidence for a lack of chromospheric and photometric activity of the host star
which, therefore, make a negligible contribution to the offset. We measure
abundances for Na and O that are consistent with solar to supersolar, with
abundances relative to solar values of and ,
respectively. We complement the transmission spectrum with new thermal emission
constraints from Spitzer observations at 3.6 and m, which are best
explained by the spectrum of an atmosphere with a temperature decreasing with
altitude. A fit to the spectrum assuming an isothermal blackbody atmosphere
constrains the dayside temperature to be =K.Comment: Accepted for publication in MNRA
Critical success factors for high routine immunization performance: A case study of Senegal
Background: The essential components of a vaccine delivery system are well-documented, but robust evidence is lacking on how policies and implementation strategies are operationalized to drive catalytic improvements in coverage. To address this gap, we identified success factors that supported improvements in routine immunization coverage in Senegal, especially from 2000 to 2019. Methods: We identified Senegal as an exemplar in the delivery of childhood vaccines through analysis of DTP1 and DTP3 coverage data. Through interviews and focus group discussions at the national, regional, district, health facility, and community-level, we investigated factors that contributed to high and sustained vaccination coverage. We conducted a thematic analysis through application of implementation science frameworks to determine critical success factors. We triangulated these findings with quantitative analyses using publicly available data. Results: The following success factors emerged: 1) Strong political will and prioritization of resources for immunization programming supported urgent allocation of funding and supplies; 2) Collaboration between the Ministry of Health and Social Action and external partners fostered innovation, capacity building, and efficiency; 3) Improved surveillance, monitoring, and evaluation allowed for timely and evidence-based decision making; 4) Community ownership of vaccine service delivery supported tailored programming and response to local needs; and 5) Community health workers spearheaded vaccine promotion and demand generation for vaccines. Conclusion: The vaccination program in Senegal was supported by evidence-based decision making at the national-level, alignment of priorities between governmental entities and external partners, and strong community engagement initiatives that fostered local ownership of vaccine delivery and uptake. High routine immunization coverage was likely driven by prioritization of immunization programming, improved surveillance systems, a mature and reliable community health worker program, and tailored strategies for addressing geographical, social, and cultural barriers